Early Experience and Effectiveness of Long-Acting Injectable Cabotegravir and Rilpivirine in a South Side Chicago HIV Clinic

被引：0
|
作者：
Liegeon, Geoffroy [1 ]
Kaperak, Christopher [1 ]
Friedman, Eleanor E. [1 ]
Djuricich, Paul [2 ]
Dawdani, Alicia [1 ]
Stafford, Kane [2 ]
Plotkin, Sophie [1 ]
Schmitt, Jessica [1 ]
Hazra, Aniruddha [1 ]
Christopoulos, Katerina A. [3 ]
Schneider, John A. [1 ]
Mcnulty, Moira C. [1 ]
机构：
[1] Univ Chicago, Dept Med, Chicago, IL USA
[2] Univ Chicago, Dept Pharm, Chicago, IL USA
[3] Univ Calif San Francisco, Div HIV ID & Global Med, San Francisco, CA USA
来源：
OPEN FORUM INFECTIOUS DISEASES | 2025年 / 12卷 / 03期
基金：
美国国家卫生研究院;
关键词：
cabotegravir; injectable; long-acting; people with HIV; rilpivirine; PROGRAM; CARE;
D O I：
10.1093/ofid/ofaf094
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We describe referrals and uptake of long-acting injectable cabotegravir/rilpivirine at an academic clinic in Chicago. In a pharmacy-led model, 118 (18%) people with HIV were referred and 78 (12%) initiated long-acting injectable cabotegravir/rilpivirine from 1 January 2021 to 31 May 2023. Implementation, especially for people with HIV who were not virally suppressed, requires further support for patients, providers, and clinic systems.
引用
收藏
页数：7
相关论文
共 50 条
  • [1] Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV
    van der Wekken-Pas, Lena
    Weiss, Fabian
    Simon-Zuber, Charlotte
    Sebisch, Rena
    Wiese, Carmen
    van Leeuwen, Elisabeth
    Burger, David
    Colbers, Angela
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (06) : 1468 - 1471
  • [2] Implementing long-acting injectable cabotegravir and rilpivirine in Africa
    Orkin, Chloe
    Ring, Kyle
    LANCET INFECTIOUS DISEASES, 2024, 24 (10): : 1060 - 1061
  • [3] Therapeutic review of cabotegravir/rilpivirine long-acting antiretroviral injectable and implementation considerations at an HIV specialty clinic
    Howe, Zach W.
    Norman, Sarah
    Lueken, Abbie F.
    Huesgen, Emily
    Farmer, Eric K.
    Jarrell, Kaitlyn
    Mathis, Joscelyn E.
    Bonham, Kyle W.
    Hahn, Julie
    PHARMACOTHERAPY, 2021, 41 (08): : 686 - 699
  • [4] Use of long-acting injectable cabotegravir/rilpivirine in people with HIV and adherence challenges
    Christopoulos, Katerina A.
    Hickey, Matthew D.
    Rana, Aadia
    CURRENT OPINION IN HIV AND AIDS, 2025, 20 (01) : 11 - 18
  • [5] Appropriateness of virological monitoring with long-acting injectable cabotegravir and rilpivirine
    Ripamonti, Diego
    Borghetti, Alberto
    Zazzi, Maurizio
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (10) : 2720 - 2724
  • [6] Proviral HIV DNA sequencing to inform suitability for long-acting injectable cabotegravir/rilpivirine
    Alagaratnam, Jasmini
    Kelly, Niall
    Dustan, Simon
    Naous, Nadia
    Nwanbila, Modest
    Byrne, Ruth
    Girometti, Nicolo
    Asboe, David
    Taylor, Graham P.
    Boffito, Marta
    AIDS, 2025, 39 (01) : 95 - 98
  • [7] Comparison of At-Home Versus In-Clinic Receipt of Long-Acting Injectable Cabotegravir/Rilpivirine
    Kirk, Stephanie E.
    Young, Christina
    Berry, Hayley
    Hanson, Rochelle
    Moreland, Angela
    Fonner, Virginia
    Gebregziabher, Mulugeta
    Williams, Jamila
    Meissner, Eric G.
    CLINICAL INFECTIOUS DISEASES, 2024,
  • [8] Acceptability of Long-Acting Cabotegravir plus Rilpivirine in a Large, Urban, Ambulatory HIV Clinic
    Luc, Casey Morgan
    Max, Blake
    Perez, Sarah
    Herrera, Kara
    Huhn, Gregory
    Dworkin, Mark S.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 97 (04) : 409 - 415
  • [9] Effectiveness of long-acting ART with cabotegravir/rilpivirine in the ICONA cohort
    Gagliardini, Roberta
    De Benedittis, Sara
    Tavelli, Alessandro
    Lapadula, Giuseppe
    Mazzotta, Valentina
    Bruzzesi, Elena
    Cervo, Adriana
    Carrozzo, Giorgia
    Sarracino, Annalisa
    Rusconi, Stefano
    Marchetti, Giulia
    Ceccherini-Silberstein, Francesca
    Antinori, Andrea
    Monforte, Antonella d'Arminio
    Muccini, Camilla
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 89 - 90
  • [10] Early Experience Implementing Long-Acting Injectable Cabotegravir/Rilpivirine for Human Immunodeficiency Virus-1 Treatment at a Ryan White-Funded Clinic in the US South
    Collins, Lauren F.
    Corbin-Johnson, Della
    Asrat, Meron
    Morton, Zoey P.
    Dance, Kaylin
    Condra, Alton
    Jenkins, Kimberly
    Todd-Turner, Marie
    Sumitani, Jeri
    Smith, Bradley L.
    Armstrong, Wendy S.
    Colasanti, Jonathan A.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (09):
12345